These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 8421440)
1. [In vitro activity of ofloxacin and ciprofloxacin against Mycobacterium tuberculosis strains]. Aysev AD Mikrobiyol Bul; 1993 Jan; 27(1):31-5. PubMed ID: 8421440 [TBL] [Abstract][Full Text] [Related]
2. [Comparison of standard proportion dilution test and Etest for Mycobacterium tuberculosis sensitivity to ofloxacin and ciprofloxacin]. Cavuşoğlu C; Ciçek-Saydam C; Burhanoğlu D; Ozkalay N; Ozkaya D; Ozçam H; Bilgiç A Mikrobiyol Bul; 2002 Jan; 36(1):118-23. PubMed ID: 12476777 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of fluoroquinolones against Mycobacterium tuberculosis. Sulochana S; Rahman F; Paramasivan CN J Chemother; 2005 Apr; 17(2):169-73. PubMed ID: 15920901 [TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid. Casal M; Gutierrez J; González J; Ruiz P Chemioterapia; 1987 Dec; 6(6):437-9. PubMed ID: 3124964 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of various methods of susceptibility to ofloxacin in strains of Mycobacterium tuberculosis. Sulochana S; Venkataraman P; Paramasivan CN Indian J Med Res; 1999 Dec; 110():186-9. PubMed ID: 10701297 [TBL] [Abstract][Full Text] [Related]
6. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines. Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582 [TBL] [Abstract][Full Text] [Related]
7. Study of the in vitro susceptibility of M. tuberculosis to ofloxacin in Spain. Spanish Study Group of M. tuberculosis resistance. Casal M; Ruiz P; Herreras A Int J Tuberc Lung Dis; 2000 Jun; 4(6):588-91. PubMed ID: 10864193 [TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand. Pracharktam R; Angkananukool K; Vibhagool A J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295 [TBL] [Abstract][Full Text] [Related]
9. Minimal inhibitory concentrations of rifabutin, ciprofloxacin, and ofloxacin against Mycobacterium tuberculosis isolated before treatment of patients in Taiwan. Chen CH; Shih JF; Lindholm-Levy PJ; Heifets LB Am Rev Respir Dis; 1989 Oct; 140(4):987-9. PubMed ID: 2552883 [TBL] [Abstract][Full Text] [Related]
10. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates. Prammananan T; Arjratanakool W; Chaiprasert A; Tingtoy N; Leechawengwong M; Asawapokee N; Leelarasamee A; Dhiraputra C Int J Tuberc Lung Dis; 2005 Feb; 9(2):216-9. PubMed ID: 15732744 [TBL] [Abstract][Full Text] [Related]
11. Activity of ciprofloxacin and other fluorinated quinolones against mycobacteria. Young LS; Berlin OG; Inderlied CB Am J Med; 1987 Apr; 82(4A):23-6. PubMed ID: 3107379 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of the new quinolone lomefloxacin against Mycobacterium tuberculosis. Piersimoni C; Morbiducci V; Bornigia S; De Sio G; Scalise G Am Rev Respir Dis; 1992 Dec; 146(6):1445-7. PubMed ID: 1333738 [TBL] [Abstract][Full Text] [Related]
13. [Comparison of in-vitro and in-vivo activities of enoxacin and ofloxacin against the Mycobacterium tuberculosis]. Xu G; Li H; Liu S Zhonghua Jie He He Hu Xi Za Zhi; 1995 Jun; 18(3):175-7, 192. PubMed ID: 8565090 [TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis. Akcali S; Surucuoglu S; Cicek C; Ozbakkaloglu B Ann Saudi Med; 2005; 25(5):409-12. PubMed ID: 16270765 [TBL] [Abstract][Full Text] [Related]
15. Uptake of ciprofloxacin and ofloxacin by 2 Brucella strains and their fluoroquinolone-resistant variants under different conditions. An in vitro study. Turkmani A; Psaroulaki A; Christidou A; Samoilis G; Mourad TA; Tabaa D; Tselentis Y Diagn Microbiol Infect Dis; 2007 Dec; 59(4):447-51. PubMed ID: 17920802 [TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro activity of fluoroquinolones against Mycobacterium tuberculosis. Karak K; De PK Indian J Med Res; 1995 Apr; 101():147-9. PubMed ID: 7751043 [TBL] [Abstract][Full Text] [Related]
17. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains]. Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950 [TBL] [Abstract][Full Text] [Related]
18. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis. Bhusal Y; Shiohira CM; Yamane N Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578 [TBL] [Abstract][Full Text] [Related]
19. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media. Kamala T; Herbert D; Venkatesan P; Paramasivan CN Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):375-8. PubMed ID: 9401493 [TBL] [Abstract][Full Text] [Related]
20. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis. Foroumadi A; Soltani F; Moshafi MH Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]